Phase 1 Safety Run-In and Phase 2 Randomized Clinical Trial of Anetumab Ravtansine and MK-3475 (Pembrolizumab) Compared to MK-3475 (Pembrolizumab) Alone for Mesothelin-Positive Malignant Pleural Mesothelioma
Phase of Trial: Phase I/II
Latest Information Update: 11 Oct 2019
Price : $35 *
At a glance
- Drugs Anetumab ravtansine (Primary) ; Pembrolizumab
- Indications Mesothelioma
- Focus Adverse reactions; Therapeutic Use
- 10 Apr 2019 Status changed from suspended to recruiting.
- 27 Feb 2019 Status changed from recruiting to suspended.
- 31 Aug 2018 Biomarkers information updated